Header Logo

MILIND JAVLE

Concepts (684)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with MILIND JAVLE's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MILIND JAVLE has written about over time.
Esophageal Neoplasms, 18 publications between 2003 and 2010, average publication date April 2006. Adenocarcinoma, 40 publications between 2003 and 2020, average publication date July 2010. Fluorouracil, 22 publications between 2005 and 2021, average publication date April 2011. Liver Neoplasms, 19 publications between 2004 and 2022, average publication date June 2012. Antineoplastic Combined Chemotherapy Protocols, 59 publications between 2004 and 2023, average publication date May 2014. Deoxycytidine, 34 publications between 2005 and 2023, average publication date October 2014. Humans, 232 publications between 1993 and 2024, average publication date October 2014. Pancreatic Neoplasms, 66 publications between 2003 and 2024, average publication date July 2015. Gallbladder Neoplasms, 20 publications between 2005 and 2023, average publication date August 2015. DNA Repair, 5 publications between 2011 and 2020, average publication date August 2016. Carcinoma, Pancreatic Ductal, 25 publications between 2006 and 2024, average publication date August 2017. Cholangiocarcinoma, 59 publications between 2004 and 2024, average publication date November 2018. Bile Ducts, Intrahepatic, 32 publications between 2006 and 2024, average publication date December 2018. Bile Duct Neoplasms, 53 publications between 2004 and 2024, average publication date February 2019. Biliary Tract Neoplasms, 19 publications between 2009 and 2023, average publication date July 2019. Phenylurea Compounds, 4 publications between 2017 and 2021, average publication date May 2020. Pyrimidines, 6 publications between 2017 and 2021, average publication date August 2020. Receptor, Fibroblast Growth Factor, Type 2, 5 publications between 2017 and 2023, average publication date March 2021. Receptor, Fibroblast Growth Factor, Type 1, 3 publications between 2021 and 2023, average publication date May 2022.

To see the data from this visualization as text, click here.
JAVLE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (684)
Explore
_
Co-Authors (184)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_